Electrosurgical systems are used by physicians to perform specific functions during surgical procedures. For example, electrosurgical systems use high frequency electrical energy to remove soft tissue such as sinus tissue, adipose tissue, meniscus, cartilage and/or sinovial tissue in a joint, or to remove portions of a disc between vertebrae (e.g., remove end-plate, remove annulus fibrosus).
However, the spacing between vertebrae not only limits the number and spacing of electrodes on the tip of an electrosurgical wand, but also limits the amount of movement possible with the electrosurgical wand during spinal procedures. For example, narrow spacing between the vertebrae in many cases does not allow a surgeon to turn the electrosurgical wand over with the wand tip within the disc between the vertebrae. Despite the physical limitations, both the portion of the disc near the adjacent upper vertebrae, and the portion of the disc near the adjacent lower vertebrae, may need to be treated. Having an electrosurgical wand with dedicated upper and lower active electrodes, along with a dedicated return electrode, may simultaneously treat both sides of the disc, but is impractical both because of space considerations and because having two active electrodes may cause excessive muscle and/or nerve stimulation. Having an electrosurgical wand a dedicated active electrode that only treats one side of the disc one side of the disc requires the surgeon to remove wand, turn the wand over, and re-insert the wand to treat the other side of the disc—a series of events required many times during a spinal procedure, rendering the procedure time consuming and impractical.
Any advance that makes the treatment of tissue in confined spaces faster and easier for the surgeon, and less traumatic for the patient, would provide a competitive advantage.
For a detailed description of exemplary embodiments, reference will now be made to the accompanying drawings in which:
Certain terms are used throughout the following description and claims to refer to particular system components. As one skilled in the art will appreciate, companies that design and manufacture electrosurgical systems may refer to a component by different names. This document does not intend to distinguish between components that differ in name but not function.
In the following discussion and in the claims, the terms “including” and “comprising” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to . . . .” Also, the term “couple” or “couples” is intended to mean either an indirect or direct connection. Thus, if a first device couples to a second device, that connection may be through a direct connection or through an indirect electrical connection via other devices and connections.
Reference to a singular item includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said” and “the” include plural references unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement serves as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Lastly, it is to be appreciated that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
“Active electrode” shall mean an electrode of an electrosurgical wand which produces an electrically-induced tissue-altering effect when brought into contact with, or close proximity to, a tissue targeted for treatment.
“Return electrode” shall mean an electrode of an electrosurgical wand which serves to provide a current flow path for electrons with respect to an active electrode, and/or an electrode of an electrical surgical wand which does not itself produce an electrically-induced tissue-altering effect on tissue targeted for treatment.
“Substantially”, in relation to exposed surface areas, shall mean that exposed surface areas as between two electrodes are same, or differ by no more than twenty five (25) percent.
A fluid conduit said to be “within” an elongate shaft shall include not only a separate fluid conduit that physically resides within an internal volume of the elongate shaft, but also situations where the internal volume of the elongate shaft is itself the fluid conduit.
Where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein.
All existing subject matter mentioned herein (e.g., publications, patents, patent applications and hardware) is incorporated by reference herein in its entirety except insofar as the subject matter may conflict with that of the present invention (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.
Before the various embodiments are described in detail, it is to be understood that this invention is not limited to particular variations set forth herein as various changes or modifications may be made, and equivalents may be substituted, without departing from the spirit and scope of the invention. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.
Though not visible in the view of
Still referring to
In some embodiments the electrosurgical system 100 also comprises a foot pedal assembly 130. The foot pedal assembly 130 may comprise one or more pedal devices 132 and 134, a flexible multi-conductor cable 136 and a pedal connector 138. While only two pedal devices 132, 134 are shown, one or more pedal devices may be implemented. The outer surface 122 of the controller 104 may comprise a corresponding connector 140 that couples to the pedal connector 138. A physician may use the foot pedal assembly 130 to control various aspects of the controller 104, such as the operational mode. For example, a pedal device, such as pedal device 132, may be used for on-off control of the application of radio frequency (RF) energy to the wand 102, and more specifically for control of energy in an ablation mode. A second pedal device, such as pedal device 134, may be used to control and/or set the operational mode of the electrosurgical system. For example, actuation of pedal device 134 may switch between energy levels of an ablation mode.
The electrosurgical system 100 of the various embodiments may have a variety of operational modes. One such mode employs Coblation® technology. In particular, the assignee of the present disclosure is the owner of Coblation® technology. Coblation® technology involves the application of a radio frequency (RF) signal between one or more active electrodes and one or more return electrodes of the wand 102 to develop high electric field intensities in the vicinity of the target tissue. The electric field intensities may be sufficient to vaporize an electrically conductive fluid over at least a portion of the one or more active electrodes in the region between the one or more active electrodes and the target tissue. The electrically conductive fluid may be inherently present in the body, such as blood, or in some cases extracelluar or intracellular fluid. In other embodiments, the electrically conductive fluid may be a liquid or gas, such as isotonic saline. In some embodiments, such as surgical procedures on a disc between vertebrae, the electrically conductive fluid is delivered in the vicinity of the active electrode and/or to the target site by the wand 102, such as by way of the internal passage and flexible tubular member 116.
When the electrically conductive fluid is heated to the point that the atoms of the fluid vaporize faster than the atoms recondense, a gas is formed. When sufficient energy is applied to the gas, the atoms collide with each other causing a release of electrons in the process, and an ionized gas or plasma is formed (the so-called “fourth state of matter”). Stated otherwise, plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through the gas, or by directing electromagnetic waves into the gas. The methods of plasma formation give energy to free electrons in the plasma directly, electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.
As the density of the plasma becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases such that subsequently injected electrons cause impact ionization within the plasma. When the ionic particles in the plasma layer have sufficient energy (e.g., 3.5 electron-Volt (eV) to 5 eV), collisions of the ionic particles with molecules that make up the target tissue break molecular bonds of the target tissue, dissociating molecules into free radicals which then combine into gaseous or liquid species. Often, the electrons in the plasma carry the electrical current or absorb the electromagnetic waves and, therefore, are hotter than the ionic particles. Thus, the electrons, which are carried away from the target tissue toward the active or return electrodes, carry most of the plasma's heat, enabling the ionic particles to break apart the target tissue molecules in a substantially non-thermal manner.
By means of the molecular dissociation (as opposed to thermal evaporation or carbonization), the target tissue is volumetrically removed through molecular dissociation of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. The molecular dissociation completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as occurs in related art electrosurgical desiccation and vaporization. A more detailed description of the molecular dissociation can be found in commonly assigned U.S. Pat. No. 5,697,882, the complete disclosure of which is incorporated herein by reference.
In addition to the Coblation® mode, the electrosurgical system 100 of
The energy density produced by electrosurgical system 100 at the distal end 108 of the wand 102 may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and/or sharp edges on the electrode surfaces; electrode materials; applied voltage; current limiting of one or more electrodes (e.g., by placing an inductor in series with an electrode); electrical conductivity of the fluid in contact with the electrodes; density of the conductive fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Since different tissue structures have different molecular bonds, the electrosurgical system 100 may be configured to produce energy sufficient to break the molecular bonds of certain tissue but insufficient to break the molecular bonds of other tissue. For example, fatty tissue (e.g., adipose) has double bonds that require an energy level higher than 4 eV to 5 eV (i.e., on the order of about 8 eV) to break. Accordingly, the Coblation® technology in some operational modes does not ablate such fatty tissue; however, the Coblation® technology at the lower energy levels may be used to effectively ablate cells to release the inner fat content in a liquid form. Other modes may have increased energy such that the double bonds can also be broken in a similar fashion as the single bonds (e.g., increasing voltage or changing the electrode configuration to increase the current density at the electrodes).
A more complete description of the various phenomena can be found in commonly assigned U.S. Pat. Nos. 6,355,032; 6,149,120 and 6,296,136, the complete disclosures of which are incorporated herein by reference.
In embodiments where the elongate shaft is metallic, the distal end 108 may further comprise a non-conductive spacer 200 coupled to the elongate shaft 106. In some cases the spacer 200 is ceramic, but other non-conductive materials resistant to degradation when exposed to plasma may be equivalently used (e.g., glass). The spacer 200 supports electrodes of conductive material, with illustrative electrodes labeled 202 and 204 in
Each electrode 202 and 204 defines an exposed surface area of conductive material, and in accordance with at least some embodiments the exposed surface area as between the upper electrode 202 and the lower electrode 204 is substantially the same. In the particular embodiment of
In accordance with at least some embodiments, not only do the electrodes define substantially the same exposed surface area as between the upper and lower electrodes, but also the shape as between the upper and lower electrodes is symmetric. In particular, the upper electrode 202 defines a particular shape, and likewise the lower electrode defines a particular shape. The shapes defined by the electrodes 202 and 204 are symmetric about the plane P that bisects the thickness T. More particularly still, in some embodiments the electrodes 202 and 204 are mirror images of each other reflected about the plane P that bisects the thickness. In other embodiments, the shape of the electrodes may be non-symmetrical about the plane P, even if the exposed surface areas are substantially the same.
Still referring to
In some embodiments saline is delivered to the distal end 108 of wand, possibly to aid in plasma creation. Still referring to
In yet still further embodiments, aspiration is provided at the distal end 108 of the wand 102.
Having the straight portions 203 and 205 residing outside a boundary defined by the elongate shaft 106 and/or spacer 200 provides an operational aspect where tissue to be removed is not removed by being fully ablated; rather, the physical relationship enables “slicing” of the tissue.
The internal conduit 400 also serves as the aspiration route. In particular,
Likewise, the elongate shaft 106 of
As illustrated in
While illustrative wand connector 114 is shown to have the tab 600 and male electrical pins 602, and controller connector 120 is shown to have the slot 700 and female electrical pins 702, in alternative embodiments the wand connector has the female electrical pins and slot, and the controller connector 120 has the tab and male electrical pins, or other combination. In other embodiments, the arrangement of the pins within the connectors may enable only a single orientation for connection of the connectors, and thus the tab and slot arrangement may be omitted. In yet still other embodiments, other mechanical arrangements to ensure the wand connector and controller connector couple in only one orientation may be equivalently used. In the case of a wand with only two electrodes, and which electrodes may be either active or return electrodes as the physical situation dictates, there may be no need to ensure the connectors couple in a particular orientation.
ROM 804 stores instructions executable by the processor 800. In particular, the ROM 804 may comprise a software program that implements the various embodiments of periodically reducing voltage generator output to change position of the plasma relative to the electrodes of the wand (discussed more below), as well as interfacing with the user by way of the display device 124 and/or the foot pedal assembly 130 (
Voltage generator 816 generates selectable alternating current (AC) voltages that are applied to the electrodes of the wand 102. In the various embodiments, the voltage generator defines two terminals 824 and 826. In accordance with the various embodiments, the voltage generator generates an alternating current (AC) voltage across the terminals 824 and 826. In at least some embodiments the voltage generator 816 is electrically “floated” from the balance of the supply power in the controller 104, and thus the voltage on terminals 824, 826, when measured with respect to the earth ground or common (e.g., common 828) within the controller 104, may or may not show a voltage difference even when the voltage generator 816 is active.
The voltage generated and applied between the active terminal 624 and return terminal 626 by the voltage generator 616 is a RF signal that, in some embodiments, has a frequency of between about 5 kilo-Hertz (kHz) and 20 Mega-Hertz (MHz), in some cases being between about 30 kHz and 2.5 MHz, often between about 100 kHz and 200 kHz. In applications near the spine, a frequency of about 100 kHz appears most therapeutic. The RMS (root mean square) voltage generated by the voltage generator 816 may be in the range from about 5 Volts (V) to 1000 V, preferably being in the range from about 10 V to 500 V, often between about 100 V to 350 V depending on the active electrode size and the operating frequency. The peak-to-peak voltage generated by the voltage generator 816 for ablation or cutting in some embodiments is a square wave form in the range of 10 V to 2000 V and in some cases in the range of 100 V to 1800 V and in other cases in the range of about 28 V to 1200 V, often in the range of about 100 V to 320V peak-to-peak (again, depending on the electrode size and the operating frequency).
Still referring to the voltage generator 816, the voltage generator 816 delivers average power levels ranging from several milliwatts to hundreds of watts per electrode, depending on the voltage applied for the target tissue being treated, and/or the maximum allowed temperature selected for the wand 102. The voltage generator 816 is configured to enable a user to select the voltage level according to the specific requirements of a particular procedure. A description of one suitable voltage generator 816 can be found in commonly assigned U.S. Pat. Nos. 6,142,992 and 6,235,020, the complete disclosure of both patents are incorporated herein by reference for all purposes.
In some embodiments, the various operational modes of the voltage generator 816 may be controlled by way of digital-to-analog converter 806. That is, for example, the processor 800 may control the output voltage by providing a variable voltage to the voltage generator 816, where the voltage provided is proportional to the voltage generated by the voltage generator 816. In other embodiments, the processor 800 may communicate with the voltage generator by way of one or more digital output signals from the digital output 808 device, or by way of packet based communications using the communication device 812 (connection not specifically shown so as not to unduly complicate
As alluded to above, in certain electrosurgical procedures, such as discectomy procedures, it may not be possible to turn the wand 102 over when the distal end 108 is within a disc (i.e., the distance between vertebrae is smaller than the width of the wand); however, the surgical effect desired (e.g., ablation) may need to be applied to an upper portion of the disc, then a lower portion of the disc, and so on, as the distal end 108 of the wand moves within the disc. The various embodiments address the difficulties noted by a combination of an operational mode of the controller 104 and the relationship of illustrative electrodes 202 and 204. The operational mode of the controller 104 and relationship of the electrodes 202 and 204 will be discussed after a short digression into characteristics plasma creation and continuance.
In particular, in situations where plasma has yet to form but could form around any one of multiple electrodes, plasma tends to form in areas of highest current density. For example, as between two illustrative electrodes having the same exposed surface area of conductive material and same applied RMS voltage, during periods of time when RF energy is being applied across the electrodes but before plasma creation, the highest current density forms near the electrode closest to tissue of the patient. However, once plasma is formed a reduction in applied RF energy (to a point) will not necessarily extinguish the plasma, even in situations where another electrode would facilitate a higher current density if plasma creation was started anew.
In accordance with the various embodiments, a controller 104 is operated in a manner where plasma is created near a first electrode, and thus ablation takes place for a period of time, and then the plasma is extinguished (e.g., by a sufficient reduction in RF energy applied to the electrodes). Thereafter, the RF energy is again applied and thus plasma is created near whichever electrode produces the highest current density. Under the assumption that the ablation caused by the first plasma proximate to the first electrode removed tissue near the first electrode, when the RF energy is again applied in all likelihood the second electrode will then be closer to tissue than the first electrode, and thus the highest current density will be present near the second electrode and the plasma will be created near the second electrode.
More specifically, and in reference again to
In the various embodiments the RF energy is applied for a predetermined period of time, in some cases between and including 50 milliseconds (ms) and 2000 ms, and in some cases 500 ms. As for reduction of RF energy sufficient to extinguish the plasma, in some cases the RF energy is reduced to zero (i.e., the voltage generator is turned off), but in other cases the RF energy remains non-zero, but is reduced an amount sufficient to extinguish the plasma where the amount of reduction is dependent upon the specific electrode configuration (e.g., in a particular electrode configuration a 50% reduction in RF energy may be sufficient). In some cases, the RF energy is reduced for at least 20 ms, and in some cases 50 ms. Before proceeding it should be understood that the RF energy applied across the terminals 824 and 826, and thus applied across the electrodes 202 and 204, is an AC voltage. By definition, and AC voltage swings from a positive value to a negative value, including a zero-crossing; however, changes in voltage associated with an applied AC waveform (e.g., sinusoidal, square) shall not be considered a “reduction” in voltage for purposes of this disclosure and claims.
In accordance with at least some embodiments, the cycle of producing RF energy at a particular level, reducing the RF energy, and then producing the RF energy again is an automatic function of the controller 104. Stated otherwise, once selected as the operational mode (e.g., by actuation of a foot pedal device, by interaction with switches 126, or possibly by wand specific inputs from the wand connector) when operated in the mode described the surgeon need not take action during the procedure to facilitate the cycle; rather, the cycle takes place during periods of time when the controller 104 is commanded to produce RF energy. Consider, as a specific example, a surgeon performing a discectomy. The surgeon selects an operational mode (e.g., by the switches 126), then commands production of RF energy by stepping on and holding down foot pedal device 132. In other words, stepping on and holding the foot pedal device indicates a command to produce energy. While the foot pedal device is depressed (i.e., while the controller 104 is commanded to produce RF energy), the RF energy IS produced, reduced, and re-produced in the cycle described above many times per second. Stated otherwise, in spite of the fact the surgeon has commanded the controller 104 to produce energy, the controller 104 may nevertheless reduce the RF energy, and in some cases turn the RF energy off, to extinguish the plasma as described above. Stated otherwise yet further still, forming the plasma proximate the first electrode, and then forming the plasma proximate the second electrode, is in the absence of a command provided to the electrosurgical controller to change an active electrode.
Thus, an aspect of operation is enabling the plasma to form proximate to an electrode closest to the tissue to be treated. So as not to favor one electrode over another for purposes of plasma creation, the electrodes in accordance with at least some embodiments have equal or substantially equal exposed surface areas. Moreover, when plasma forms near one electrode that electrode becomes an active electrode, while the other electrode becomes a return electrode, and their roles reverse periodically. So that each electrode has a fair opportunity to be either the active or return electrode, in embodiments where the elongate shaft 106 is metallic the elongate shaft is not electrically grounded or electrically coupled to the generator 104. Stated otherwise, having an electrically grounded metallic elongate shaft may interfere with the plasma creation aspects.
The cycle of production of energy, reduction of energy, and re-production of energy may be implemented in many forms. For example, in some cases when a particular operational mode is selected for the controller 104, the processor 800 executes a program that periodically commands the voltage generator 816 to reduce the RF energy (again, the reduction in some cases to zero) in order to extinguish the plasma. In yet still other embodiments, the voltage generator 816 itself may implement circuitry to perform the cycle as discussed.
Returning briefly to
However, while there may be benefits to the “slicing” action of the wire electrodes of
In embodiments where the elongate shaft is metallic, the distal end 108 may further comprise a non-conductive spacer 900 coupled to the elongate shaft 106. In some cases the spacer 200 is ceramic, but other non-conductive materials resistant to degradation when exposed to plasma may be equivalently used. The spacer 900 supports electrodes of conductive material, with illustrative electrodes labeled 902 and 904 in
In accordance with at least some embodiments, not only do the electrodes define substantially the same exposed surface area as between the upper and lower electrodes, but also the shape as between the upper and lower electrodes is symmetric. In particular, the upper electrode 902 defines a particular shape, and likewise the lower electrode defines a particular shape. The shapes defined by the electrodes 902 and 904 are symmetric about a plane that bisects the thickness T. More particularly still, in some embodiments the electrodes 202 and 204 are mirror images of each other reflected about a plane that bisects the thickness. In other embodiments, the shape of the electrodes may be non-symmetrical, even if the exposed surface areas are substantially the same.
In some embodiments saline is delivered to the distal end 108 of wand, possibly to aid in plasma creation.
The embodiments of
While the various embodiments discussed to this point have all been in relation to wands 102 having two electrodes, in yet still other embodiments more electrodes may be used. For example,
Moreover,
The above discussion is meant to be illustrative of the principles and various embodiments of the present invention. Numerous variations and modifications possible. For example, while in some cases electrodes were designated as upper electrodes and lower electrodes, such a designation was for purposes of discussion, and shall not be read to require any relationship to gravity during surgical procedures. It is intended that the following claims be interpreted to embrace all such variations and modifications.
While preferred embodiments of this disclosure have been shown and described, modifications thereof can be made by one skilled in the art without departing from the scope or teaching herein. The embodiments described herein are exemplary only and are not limiting. Because many varying and different embodiments may be made within the scope of the present inventive concept, including equivalent structures, materials, or methods hereafter though of, and because many modifications may be made in the embodiments herein detailed in accordance with the descriptive requirements of the law, it is to be understood that the details herein are to be interpreted as illustrative and not in a limiting sense.
Number | Name | Date | Kind |
---|---|---|---|
2056377 | Wappler | Oct 1939 | A |
3633425 | Sanford | Jan 1972 | A |
3659607 | Banko | May 1972 | A |
3815604 | O'Malley et al. | Jun 1974 | A |
3828780 | Morrison, Jr. et al. | Aug 1974 | A |
3901242 | Storz | Aug 1975 | A |
3920021 | Hiltebrandt | Nov 1975 | A |
3939839 | Curtiss | Feb 1976 | A |
3970088 | Morrison | Jul 1976 | A |
4040426 | Morrison, Jr. | Aug 1977 | A |
4043342 | Morrison, Jr. | Aug 1977 | A |
4074718 | Morrison, Jr. | Feb 1978 | A |
4092986 | Schneiderman | Jun 1978 | A |
4116198 | Roos | Sep 1978 | A |
4161950 | Doss et al. | Jul 1979 | A |
4181131 | Ogiu | Jan 1980 | A |
4184492 | Meinke et al. | Jan 1980 | A |
4202337 | Hren et al. | May 1980 | A |
4228800 | Degler, Jr. et al. | Oct 1980 | A |
4232676 | Herczog | Nov 1980 | A |
4248231 | Herczog et al. | Feb 1981 | A |
4269174 | Adair | May 1981 | A |
4326529 | Doss et al. | Apr 1982 | A |
4381007 | Doss | Apr 1983 | A |
4449926 | Weiss | May 1984 | A |
4474179 | Koch | Oct 1984 | A |
4476862 | Pao | Oct 1984 | A |
4483338 | Bloom et al. | Nov 1984 | A |
4512351 | Pohndorf | Apr 1985 | A |
4532924 | Auth et al. | Aug 1985 | A |
4548207 | Reimels | Oct 1985 | A |
4567890 | Ohta et al. | Feb 1986 | A |
4572214 | Nordenstrom et al. | Feb 1986 | A |
4573448 | Kambin | Mar 1986 | A |
4582057 | Auth et al. | Apr 1986 | A |
4590934 | Malis et al. | May 1986 | A |
4593691 | Lindstrom et al. | Jun 1986 | A |
4658817 | Hardy | Apr 1987 | A |
4660571 | Hess et al. | Apr 1987 | A |
4674499 | Pao | Jun 1987 | A |
4682596 | Bales et al. | Jul 1987 | A |
4706667 | Roos | Nov 1987 | A |
4727874 | Bowers et al. | Mar 1988 | A |
4765331 | Petruzzi et al. | Aug 1988 | A |
4785823 | Eggers et al. | Nov 1988 | A |
4805616 | Pao | Feb 1989 | A |
4823791 | D'Amelio et al. | Apr 1989 | A |
4832020 | Augustine | May 1989 | A |
4832048 | Cohen | May 1989 | A |
4896671 | Cunningham et al. | Jan 1990 | A |
4907589 | Cosman | Mar 1990 | A |
4920978 | Colvin | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936301 | Rexroth et al. | Jun 1990 | A |
4943290 | Rexroth et al. | Jul 1990 | A |
4958539 | Stasz et al. | Sep 1990 | A |
4966597 | Cosman | Oct 1990 | A |
4967765 | Turner et al. | Nov 1990 | A |
4976709 | Sand | Dec 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
4979948 | Geddes et al. | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5007908 | Rydell | Apr 1991 | A |
5009656 | Reimels | Apr 1991 | A |
5035696 | Rydell | Jul 1991 | A |
5047026 | Rydell | Sep 1991 | A |
5047027 | Rydell | Sep 1991 | A |
5078717 | Parins et al. | Jan 1992 | A |
5080660 | Buelna | Jan 1992 | A |
5084044 | Quint | Jan 1992 | A |
5084045 | Helenowski | Jan 1992 | A |
5085659 | Rydell | Feb 1992 | A |
5088997 | Delahuerga et al. | Feb 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5099840 | Goble | Mar 1992 | A |
5102410 | Dressel | Apr 1992 | A |
5108391 | Flachenecker et al. | Apr 1992 | A |
RE33925 | Bales et al. | May 1992 | E |
5112330 | Nishigaki et al. | May 1992 | A |
5122138 | Manwaring | Jun 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5137530 | Sand | Aug 1992 | A |
5156151 | Imran | Oct 1992 | A |
5158565 | Marcadis et al. | Oct 1992 | A |
5167659 | Ohtomo et al. | Dec 1992 | A |
5171311 | Rydell et al. | Dec 1992 | A |
5178620 | Eggers et al. | Jan 1993 | A |
5190517 | Zieve et al. | Mar 1993 | A |
5192280 | Parins | Mar 1993 | A |
5195959 | Smith | Mar 1993 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5197963 | Parins | Mar 1993 | A |
5201729 | Hertzmann et al. | Apr 1993 | A |
5207675 | Canady | May 1993 | A |
5207684 | Nobles | May 1993 | A |
5217457 | Delahuerga et al. | Jun 1993 | A |
5217459 | Kamerling | Jun 1993 | A |
5230334 | Klopotek | Jul 1993 | A |
5261410 | Alfano et al. | Nov 1993 | A |
5267994 | Gentelia et al. | Dec 1993 | A |
5267997 | Farin et al. | Dec 1993 | A |
5273524 | Fox et al. | Dec 1993 | A |
5277201 | Stern | Jan 1994 | A |
5281216 | Klicek | Jan 1994 | A |
5290273 | Tan | Mar 1994 | A |
5290282 | Casscells | Mar 1994 | A |
5300069 | Hunsberger et al. | Apr 1994 | A |
5306238 | Fleenor | Apr 1994 | A |
5312400 | Bales et al. | May 1994 | A |
5314406 | Arias et al. | May 1994 | A |
5318564 | Eggers | Jun 1994 | A |
5324254 | Phillips | Jun 1994 | A |
5330470 | Hagen | Jul 1994 | A |
5334140 | Philips | Aug 1994 | A |
5336443 | Odashima | Aug 1994 | A |
5342357 | Nardella | Aug 1994 | A |
5366443 | Eggers et al. | Nov 1994 | A |
5370675 | Edwards et al. | Dec 1994 | A |
5374261 | Yoon | Dec 1994 | A |
5374265 | Sand | Dec 1994 | A |
5375588 | Yoon | Dec 1994 | A |
5380277 | Phillips | Jan 1995 | A |
5380316 | Aita | Jan 1995 | A |
5383876 | Nardella | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5389096 | Aita | Feb 1995 | A |
5395312 | Desai | Mar 1995 | A |
5400267 | Denen et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5417687 | Nardella et al. | May 1995 | A |
5419767 | Eggers et al. | May 1995 | A |
5423810 | Goble et al. | Jun 1995 | A |
5423882 | Jackman et al. | Jun 1995 | A |
5429138 | Jamshidi | Jul 1995 | A |
5433739 | Sluijter et al. | Jul 1995 | A |
5436566 | Thompson et al. | Jul 1995 | A |
5437662 | Nardella | Aug 1995 | A |
5438302 | Goble | Aug 1995 | A |
5439446 | Barry | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5451224 | Goble et al. | Sep 1995 | A |
5454809 | Janssen | Oct 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5496312 | Klicek | Mar 1996 | A |
5496314 | Eggers | Mar 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5514130 | Baker | May 1996 | A |
5542945 | Fritzsch | Aug 1996 | A |
5554152 | Aita | Sep 1996 | A |
5556397 | Long et al. | Sep 1996 | A |
5562703 | Desai | Oct 1996 | A |
5569242 | Lax et al. | Oct 1996 | A |
5571100 | Goble et al. | Nov 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5584872 | LaFontaine et al. | Dec 1996 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5617854 | Munsif | Apr 1997 | A |
5618587 | Markle et al. | Apr 1997 | A |
5626136 | Webster, Jr. | May 1997 | A |
5626576 | Janssen | May 1997 | A |
5632761 | Smith et al. | May 1997 | A |
5633578 | Eggers et al. | May 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5660836 | Knowlton | Aug 1997 | A |
5662680 | Desai | Sep 1997 | A |
5676693 | LaFontaine et al. | Oct 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5697281 | Eggers et al. | Dec 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5700262 | Acosta et al. | Dec 1997 | A |
5720744 | Eggleston et al. | Feb 1998 | A |
5725524 | Mulier et al. | Mar 1998 | A |
5762629 | Kambin | Jun 1998 | A |
5766153 | Eggers et al. | Jun 1998 | A |
5766252 | Henry et al. | Jun 1998 | A |
5785705 | Baker | Jul 1998 | A |
5807306 | Shapland et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5810809 | Rydell | Sep 1998 | A |
5817033 | Desantis et al. | Oct 1998 | A |
5820580 | Edwards et al. | Oct 1998 | A |
5823955 | Kuck et al. | Oct 1998 | A |
5836875 | Webster, Jr. | Nov 1998 | A |
5843019 | Eggers et al. | Dec 1998 | A |
5846196 | Siekmeyer et al. | Dec 1998 | A |
5849009 | Bernaz | Dec 1998 | A |
5860951 | Eggers | Jan 1999 | A |
5860974 | Abele | Jan 1999 | A |
5860975 | Goble et al. | Jan 1999 | A |
5871469 | Eggers et al. | Feb 1999 | A |
5871470 | McWha | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5877289 | Thorpe et al. | Mar 1999 | A |
5885277 | Korth | Mar 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5891134 | Goble et al. | Apr 1999 | A |
5897553 | Mulier | Apr 1999 | A |
5902272 | Eggers et al. | May 1999 | A |
5916214 | Cosio et al. | Jun 1999 | A |
5925042 | Gough et al. | Jul 1999 | A |
5935083 | Williams | Aug 1999 | A |
5941869 | Patterson et al. | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5954716 | Sharkey et al. | Sep 1999 | A |
5980504 | Sharkey et al. | Nov 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6007570 | Sharkey et al. | Dec 1999 | A |
6013076 | Goble et al. | Jan 2000 | A |
6014584 | Hofmann et al. | Jan 2000 | A |
6015406 | Goble et al. | Jan 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6027501 | Goble et al. | Feb 2000 | A |
6036681 | Hooven | Mar 2000 | A |
6039734 | Goble et al. | Mar 2000 | A |
6045532 | Eggers et al. | Apr 2000 | A |
6047700 | Eggers et al. | Apr 2000 | A |
6053172 | Hovda et al. | Apr 2000 | A |
6056746 | Goble et al. | May 2000 | A |
6063079 | Hovda et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6068628 | Fanton et al. | May 2000 | A |
6073051 | Sharkey et al. | Jun 2000 | A |
6074386 | Goble et al. | Jun 2000 | A |
6086584 | Miller | Jul 2000 | A |
6090106 | Goble et al. | Jul 2000 | A |
6093186 | Goble et al. | Jul 2000 | A |
6093187 | Lecuyer | Jul 2000 | A |
6095149 | Sharkey et al. | Aug 2000 | A |
6096036 | Bowe et al. | Aug 2000 | A |
6102046 | Weinstein et al. | Aug 2000 | A |
6105581 | Eggers et al. | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6117109 | Eggers et al. | Sep 2000 | A |
6122549 | Sharkey et al. | Sep 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6146380 | Racz et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6159194 | Eggers et al. | Dec 2000 | A |
6159208 | Hovda et al. | Dec 2000 | A |
6168593 | Sharkey et al. | Jan 2001 | B1 |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6176857 | Ashley | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6179836 | Eggers et al. | Jan 2001 | B1 |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6187048 | Milner et al. | Feb 2001 | B1 |
6190381 | Olsen et al. | Feb 2001 | B1 |
6203542 | Ellsberry et al. | Mar 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6214001 | Casscells et al. | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6228078 | Eggers | May 2001 | B1 |
6228081 | Goble | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6237604 | Burnside et al. | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6245107 | Ferree | Jun 2001 | B1 |
6254600 | Willink et al. | Jul 2001 | B1 |
6258086 | Ashley et al. | Jul 2001 | B1 |
6261286 | Goble et al. | Jul 2001 | B1 |
6261311 | Sharkey et al. | Jul 2001 | B1 |
6264650 | Hovda et al. | Jul 2001 | B1 |
6264651 | Underwood et al. | Jul 2001 | B1 |
6264652 | Eggers et al. | Jul 2001 | B1 |
6270460 | McCartan et al. | Aug 2001 | B1 |
6273861 | Bates et al. | Aug 2001 | B1 |
6277112 | Underwood et al. | Aug 2001 | B1 |
6280441 | Ryan | Aug 2001 | B1 |
6283961 | Underwood et al. | Sep 2001 | B1 |
6293942 | Goble et al. | Sep 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6306134 | Goble et al. | Oct 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6312408 | Eggers et al. | Nov 2001 | B1 |
6319250 | Falwell et al. | Nov 2001 | B1 |
6322549 | Eggers et al. | Nov 2001 | B1 |
6330478 | Lee et al. | Dec 2001 | B1 |
6355032 | Hovda et al. | Mar 2002 | B1 |
6363937 | Hovda et al. | Apr 2002 | B1 |
6364877 | Goble et al. | Apr 2002 | B1 |
6379350 | Sharkey et al. | Apr 2002 | B1 |
6379351 | Thapliyal et al. | Apr 2002 | B1 |
6391025 | Weinstein et al. | May 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6416507 | Eggers et al. | Jul 2002 | B1 |
6416508 | Eggers et al. | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6428576 | Haldimann | Aug 2002 | B1 |
6432103 | Ellsberry et al. | Aug 2002 | B1 |
6443988 | Felt et al. | Sep 2002 | B2 |
6461357 | Sharkey et al. | Oct 2002 | B1 |
6464695 | Hovda et al. | Oct 2002 | B2 |
6468270 | Hovda et al. | Oct 2002 | B1 |
6468274 | Alleyne et al. | Oct 2002 | B1 |
6468275 | Wampler et al. | Oct 2002 | B1 |
6482201 | Olsen et al. | Nov 2002 | B1 |
6497704 | Ein-Gal | Dec 2002 | B2 |
6500173 | Underwood et al. | Dec 2002 | B2 |
6508839 | Lambrecht et al. | Jan 2003 | B1 |
6517498 | Burbank et al. | Feb 2003 | B1 |
6530922 | Cosman | Mar 2003 | B2 |
6540741 | Underwood et al. | Apr 2003 | B1 |
6558390 | Cragg | May 2003 | B2 |
6562033 | Shah et al. | May 2003 | B2 |
6575968 | Eggers et al. | Jun 2003 | B1 |
6578579 | Burnside | Jun 2003 | B2 |
6589237 | Woloszko et al. | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6604003 | Fredricks et al. | Aug 2003 | B2 |
6611793 | Burnside et al. | Aug 2003 | B1 |
6620155 | Underwood et al. | Sep 2003 | B2 |
6620156 | Garito et al. | Sep 2003 | B1 |
6622731 | Daniel et al. | Sep 2003 | B2 |
6632193 | Davison et al. | Oct 2003 | B1 |
6632220 | Eggers et al. | Oct 2003 | B1 |
6635034 | Cosmescu | Oct 2003 | B1 |
6635087 | Angelucci et al. | Oct 2003 | B2 |
6645247 | Ferree | Nov 2003 | B2 |
6679886 | Weikel et al. | Jan 2004 | B2 |
6699244 | Carranza et al. | Mar 2004 | B2 |
6712811 | Underwood et al. | Mar 2004 | B2 |
6726684 | Woloszko et al. | Apr 2004 | B1 |
6740093 | Hochschuler et al. | May 2004 | B2 |
6746451 | Middleton et al. | Jun 2004 | B2 |
6749604 | Eggers et al. | Jun 2004 | B1 |
6749605 | Ashley et al. | Jun 2004 | B2 |
6749608 | Garito et al. | Jun 2004 | B2 |
6758846 | Goble et al. | Jul 2004 | B2 |
6761718 | Madsen | Jul 2004 | B2 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6772012 | Woloszko et al. | Aug 2004 | B2 |
6780178 | Palanker et al. | Aug 2004 | B2 |
6780180 | Goble et al. | Aug 2004 | B1 |
6802842 | Ellman et al. | Oct 2004 | B2 |
6827716 | Ryan et al. | Dec 2004 | B2 |
6837884 | Woloszko | Jan 2005 | B2 |
6837887 | Woloszko et al. | Jan 2005 | B2 |
6837888 | Ciarrocca et al. | Jan 2005 | B2 |
6878155 | Sharkey et al. | Apr 2005 | B2 |
6918908 | Bonner et al. | Jul 2005 | B2 |
6920883 | Bessette et al. | Jul 2005 | B2 |
6921399 | Carmel et al. | Jul 2005 | B2 |
6929640 | Underwood et al. | Aug 2005 | B1 |
6949096 | Davison et al. | Sep 2005 | B2 |
6960204 | Eggers et al. | Nov 2005 | B2 |
6974453 | Woloszko et al. | Dec 2005 | B2 |
6974480 | Messerli et al. | Dec 2005 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6991631 | Woloszko et al. | Jan 2006 | B2 |
6997885 | Lubock et al. | Feb 2006 | B2 |
6997925 | Maguire et al. | Feb 2006 | B2 |
7001431 | Bao et al. | Feb 2006 | B2 |
7004941 | Tvinnereim et al. | Feb 2006 | B2 |
7014633 | Cragg | Mar 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7070596 | Woloszko et al. | Jul 2006 | B1 |
7090672 | Underwood et al. | Aug 2006 | B2 |
7094215 | Davison et al. | Aug 2006 | B2 |
7104986 | Hovda et al. | Sep 2006 | B2 |
7104989 | Skarda | Sep 2006 | B2 |
7108696 | Daniel et al. | Sep 2006 | B2 |
7131969 | Hovda et al. | Nov 2006 | B1 |
7169143 | Eggers et al. | Jan 2007 | B2 |
7172591 | Harano et al. | Feb 2007 | B2 |
7179225 | Shluzas et al. | Feb 2007 | B2 |
7179255 | Lettice et al. | Feb 2007 | B2 |
7186234 | Dahla et al. | Mar 2007 | B2 |
7192428 | Eggers et al. | Mar 2007 | B2 |
7201750 | Eggers et al. | Apr 2007 | B1 |
7217268 | Eggers et al. | May 2007 | B2 |
7241293 | Davison | Jul 2007 | B2 |
7241294 | Reschke | Jul 2007 | B2 |
7270658 | Woloszko et al. | Sep 2007 | B2 |
7270659 | Hovda et al. | Sep 2007 | B2 |
7270661 | Dahla et al. | Sep 2007 | B2 |
7276063 | Davison et al. | Oct 2007 | B2 |
7278972 | Lamoureux et al. | Oct 2007 | B2 |
7297143 | Woloszko et al. | Nov 2007 | B2 |
7297145 | Woloszko et al. | Nov 2007 | B2 |
7318823 | Sharps et al. | Jan 2008 | B2 |
7331956 | Hovda et al. | Feb 2008 | B2 |
RE40156 | Sharps et al. | Mar 2008 | E |
7357798 | Sharps et al. | Apr 2008 | B2 |
7387625 | Hovda et al. | Jun 2008 | B2 |
7393351 | Woloszko et al. | Jul 2008 | B2 |
7419488 | Ciarrocca et al. | Sep 2008 | B2 |
7429260 | Underwood et al. | Sep 2008 | B2 |
7429262 | Woloszko et al. | Sep 2008 | B2 |
7435247 | Woloszko et al. | Oct 2008 | B2 |
7442191 | Hovda et al. | Oct 2008 | B2 |
7445618 | Eggers et al. | Nov 2008 | B2 |
7449021 | Underwood et al. | Nov 2008 | B2 |
7462178 | Woloszko et al. | Dec 2008 | B2 |
7468059 | Eggers et al. | Dec 2008 | B2 |
7491200 | Underwood et al. | Feb 2009 | B2 |
7507236 | Eggers et al. | Mar 2009 | B2 |
7572251 | Davison et al. | Aug 2009 | B1 |
7628780 | Bonner et al. | Dec 2009 | B2 |
7632267 | Dahla | Dec 2009 | B2 |
7682368 | Bombard et al. | Mar 2010 | B1 |
7691101 | Davison et al. | Apr 2010 | B2 |
7704249 | Woloszko et al. | Apr 2010 | B2 |
7708733 | Sanders et al. | May 2010 | B2 |
7883515 | Kear | Feb 2011 | B2 |
7951141 | Sharps et al. | May 2011 | B2 |
7976554 | Newell et al. | Jul 2011 | B2 |
8292887 | Woloszko et al. | Oct 2012 | B2 |
20020029036 | Goble et al. | Mar 2002 | A1 |
20020049438 | Sharkey et al. | Apr 2002 | A1 |
20020082698 | Parenteau et al. | Jun 2002 | A1 |
20020120337 | Cauthen | Aug 2002 | A1 |
20030013986 | Saadat | Jan 2003 | A1 |
20030088245 | Woloszko et al. | May 2003 | A1 |
20030130655 | Woloszko et al. | Jul 2003 | A1 |
20030130738 | Hovda et al. | Jul 2003 | A1 |
20030158545 | Hovda et al. | Aug 2003 | A1 |
20030171743 | Tasto et al. | Sep 2003 | A1 |
20030208196 | Stone | Nov 2003 | A1 |
20030212396 | Eggers et al. | Nov 2003 | A1 |
20040087937 | Eggers et al. | May 2004 | A1 |
20040116922 | Hovda et al. | Jun 2004 | A1 |
20040127893 | Hovda | Jul 2004 | A1 |
20040230190 | Dahla et al. | Nov 2004 | A1 |
20050004634 | Ricart et al. | Jan 2005 | A1 |
20050043682 | Kucklick et al. | Feb 2005 | A1 |
20050059862 | Phan | Mar 2005 | A1 |
20050096645 | Wellman et al. | May 2005 | A1 |
20050261754 | Woloszko et al. | Nov 2005 | A1 |
20050267553 | Staunton et al. | Dec 2005 | A1 |
20050288665 | Woloszko et al. | Dec 2005 | A1 |
20060036237 | Davison et al. | Feb 2006 | A1 |
20060095031 | Ormsby | May 2006 | A1 |
20060178670 | Woloszko et al. | Aug 2006 | A1 |
20060189971 | Tasto et al. | Aug 2006 | A1 |
20060253117 | Hovda et al. | Nov 2006 | A1 |
20060259025 | Dahla | Nov 2006 | A1 |
20070106288 | Woloszko et al. | May 2007 | A1 |
20070149966 | Dahla et al. | Jun 2007 | A1 |
20070161981 | Sanders et al. | Jul 2007 | A1 |
20070208334 | Woloszko et al. | Sep 2007 | A1 |
20070208335 | Woloszko et al. | Sep 2007 | A1 |
20070282323 | Woloszko et al. | Dec 2007 | A1 |
20080015565 | Davison | Jan 2008 | A1 |
20080243117 | Sharps et al. | Oct 2008 | A1 |
20090105543 | Miller et al. | Apr 2009 | A1 |
20090125011 | Behzadian | May 2009 | A1 |
20090299220 | Field et al. | Dec 2009 | A1 |
20100114110 | Taft et al. | May 2010 | A1 |
20100204693 | Sanders et al. | Aug 2010 | A1 |
20110112373 | Ainsworth et al. | May 2011 | A1 |
20110288619 | Pianca | Nov 2011 | A1 |
Number | Date | Country |
---|---|---|
3245570 | Jun 1984 | DE |
3530335 | Mar 1987 | DE |
3930451 | Mar 1991 | DE |
9490466 | Jul 1996 | DE |
515 867 | Dec 1992 | EP |
0703461 | Mar 1996 | EP |
0740926 | Nov 1996 | EP |
0754437 | Jan 1997 | EP |
719162 | Nov 1997 | EP |
774926 | Jun 1999 | EP |
0694290 | Nov 2000 | EP |
886495 | Feb 2003 | EP |
2313949 | Jan 1977 | FR |
2 308 979 | Jul 1997 | GB |
2 308 980 | Jul 1997 | GB |
2 308 981 | Jul 1997 | GB |
2 327 350 | Jan 1999 | GB |
2 327 351 | Jan 1999 | GB |
2 327 352 | Jan 1999 | GB |
57-57802 | Apr 1982 | JP |
57-117843 | Jul 1982 | JP |
10504732 | May 1998 | JP |
9003152 | Apr 1990 | WO |
9007303 | Jul 1990 | WO |
9221278 | Dec 1992 | WO |
9313816 | Jul 1993 | WO |
9320747 | Oct 1993 | WO |
9404220 | Mar 1994 | WO |
9408524 | Apr 1994 | WO |
9408654 | Apr 1994 | WO |
9414383 | Jul 1994 | WO |
9426228 | Nov 1994 | WO |
9505781 | Mar 1995 | WO |
9505867 | Mar 1995 | WO |
9509576 | Apr 1995 | WO |
9530373 | Nov 1995 | WO |
9534259 | Dec 1995 | WO |
9600042 | Jan 1996 | WO |
9607360 | Mar 1996 | WO |
9620652 | Jul 1996 | WO |
9623449 | Aug 1996 | WO |
9639914 | Dec 1996 | WO |
9641574 | Dec 1996 | WO |
9700070 | Jan 1997 | WO |
9700646 | Jan 1997 | WO |
9700647 | Jan 1997 | WO |
9723169 | Jul 1997 | WO |
9724073 | Jul 1997 | WO |
9724074 | Jul 1997 | WO |
9724992 | Jul 1997 | WO |
9724993 | Jul 1997 | WO |
9724994 | Jul 1997 | WO |
9748345 | Dec 1997 | WO |
9748346 | Dec 1997 | WO |
9800070 | Jan 1998 | WO |
9801087 | Jan 1998 | WO |
9803117 | Jan 1998 | WO |
9803220 | Jan 1998 | WO |
9807468 | Feb 1998 | WO |
9811944 | Mar 1998 | WO |
9814131 | Apr 1998 | WO |
9817190 | Apr 1998 | WO |
9827879 | Jul 1998 | WO |
9827880 | Jul 1998 | WO |
9903414 | Jan 1999 | WO |
9920185 | Apr 1999 | WO |
9942037 | Aug 1999 | WO |
9947058 | Sep 1999 | WO |
9951155 | Oct 1999 | WO |
9951158 | Oct 1999 | WO |
0001313 | Jan 2000 | WO |
0007507 | Feb 2000 | WO |
0010475 | Mar 2000 | WO |
0062698 | Oct 2000 | WO |
0071043 | Nov 2000 | WO |
0126570 | Apr 2001 | WO |
0187154 | May 2001 | WO |
0182813 | Nov 2001 | WO |
0211635 | Feb 2002 | WO |
0236028 | May 2002 | WO |
03024506 | Mar 2003 | WO |
03089997 | Oct 2003 | WO |
2004022155 | Mar 2004 | WO |
2005039390 | May 2005 | WO |
2005122938 | Dec 2005 | WO |
2005125287 | Dec 2005 | WO |
Entry |
---|
Barry et al., “The Effect of Radiofrequency-generated Thermal Energy on the Mechanical and Histologic Characteristics of the Arterial Wall in Vivo: Implications of Radiofrequency Angioplasty” American Heart Journal vol. 117, pp. 332-341, 1982. |
BiLAP Generator Settings, Jun. 1991. |
BiLAP IFU 910026-001 Rev A for BiLAP Model 3525, J-Hook, 4 pgs, May 20, 1991. |
BiLAP IFU 910033-002 Rev A for BiLAP Model 3527, L-Hook; BiLAP Model 3525, J-Hook; BiLAP Model 3529, High Angle, 2 pgs, Nov. 30, 1993. |
Codman & Shurtleff, Inc. “The Malis Bipolar Coagulating and Bipolar Cutting System CMC-II” brochure, early, 2 pgs, 1991. |
Codman & Shurtleff, Inc. “The Malis Bipolar Electrosurgical System CMC-III Instruction Manual” , 15 pgs, Jul. 1991. |
Cook et al., “Therapeutic Medical Devices: Application and Design”, Prentice Hall, Inc., 3pgs, 1982. |
Dennis et al. “Evolution of Electrofulguration in Control of Bleeding of Experimental Gastric Ulcers,” Digestive Diseases and Sciences, vol. 24, No. 11, 845-848, Nov. 1979. |
Dobbie, A.K., “The Electrical Aspects of Surgical Diathermy, Bio Medical Engineering” Bio-Medical Engineering vol. 4, pp. 206-216, May 1969. |
Elsasser, V.E. et al., “An Instrument for Transurethral Resection without Leakage of Current” Acta Medicotechnica vol. 24, No. 4, pp. 129-134, 1976. |
Geddes, “Medical Device Accidents: With Illustrative Cases” CRC Press, 3 pgs, 1998. |
Honig, W., “The Mechanism of Cutting in Electrosurgery” IEEE pp. 58-65, 1975. |
Kramolowsky et al. “The Urological App of Electorsurgery” J. of Urology vol. 146, pp. 669-674, 1991. |
Kramolowsky et al. “Use of 5F Bipolar Electrosurgical Probe in Endoscopic Urological Procedures” J. of Urology vol. 143, pp. 275-277, 1990. |
Lee, B et al. “Thermal Compression and Molding of Artherosclerotic Vascular Tissue with Use” JACC vol. 13(5), pp. 1167-1171, 1989. |
Letter from Department of Health to Jerry Malis dated Jan. 24, 1991, 3 pgs. |
Letter from Department of Health to Jerry Malis dated Jul. 25, 1985, 1 pg. |
Letter from Jerry Malis to FDA dated Jul. 25, 1985, 2 pgs. |
Lu, et al., “Electrical Thermal Angioplasty: Catheter Design Features, In Vitro Tissue Ablation Studies and in Vitro Experimental Findings,” Am J. Cardiol vol. 60, pp. 1117-1122, Nov. 1, 1987. |
Malis, L., “Electrosurgery, Technical Note,” J. Neursurg., vol. 85, pp. 970-975, Nov. 1996. |
Malis, L., “Excerpted from a seminar by Leonard I. Malis, M.D. at the 1995 American Association of Neurological Surgeons Meeting,” 1pg, 1995. |
Malis, L., “Instrumentation for Microvascular Neurosurgery” Cerebrovascular Surgery, vol. 1, pp. 245-260, 1985. |
Malis, L., “New Trends in Microsurgery and Applied Technology,” Advanced Technology in Neurosurgery, pp. 1-16, 1988. |
Malis, L., “The Value of Irrigation During Bipolar Coagulation” See ARTC 21602, 1 pg, Apr. 9, 1993. |
Nardella, P.C., SPIE 1068: pp. 42-49, Radio Frequency Energy and Impedance Feedback, 1989. |
O'Malley, Schaum's Outline of Theory and Problems of Basic Circuit Analysis, McGraw-Hill, 2nd Ed., pp. 3-5, 1992. |
Olsen MD, Bipolar Laparoscopic Cholecstectomy Lecture (marked confidential), 12 pgs, Oct. 7, 1991. |
Pearce, John A. “Electrosurgery”, pp. 17, 69-75, 87, John Wiley & Sons, New York, 1986. |
Pearce, John A., “Electrosurgery”, Handbook of Biomedical Engineering, chapter 3, Academic Press Inc., N.Y., pp. 98-113, 1988. |
Piercey et al., “Electrosurgical Treatment of Experimental Bleeding Canine Gastric Ulcers” Gastroenterology vol. 74(3), pp. 527-534, 1978. |
Protell et al., “Computer-Assisted Electrocoagulation: Bipolar v. Monopolar in the Treatment of Experimental Canine Gastric Ulcer Bleeding,” Gastroenterology vol. 80, No. 3, pp. 451-455, 1981. |
Ramsey et al., “A Comparison of Bipolar and Monopolar Diathermy Probes in Experimental Animals”, Urological Research vol. 13, pp. 99-102, 1985. |
Selikowitz et al., “Electric Current and Voltage Recordings on the Myocardium During Electrosurgical Procedures in Canines,” Surgery, Gynecology & Obstetrics, vol. 164, pp. 219-224, Mar. 1987. |
Shuman, “Bipolar Versus Monopolar Electrosurgery: Clinical Applications,” Dentistry Today, vol. 20, No. 12, 7 pgs, Dec. 2001. |
Slager et al. “Spark Erosion of Arteriosclerotic Plaques” Z. Kardiol. 76:Suppl. 6, pp. 67-71, 1987. |
Slager et al. “Vaporization of Atherosclerotice Plaques by Spark Erosion” JACC 5(6): pp. 1382-1386, Jun. 1985. |
Stoffels, E. et al., “Investigation on the Interaction Plasma-Bone Tissue”, E-MRS Spring Meeting, 1 pg, Jun. 18-21, 2002. |
Stoffels, E. et al., “Biomedical Applications of Plasmas”, Tutorial presented prior to the 55th Gaseous Electronics Conference in Minneapolis, MN, 41 pgs, Oct. 14, 2002. |
Stoffels, E. et al., “Plasma Interactions with Living Cells”, Eindhoven University of Technology, 1 pg, 2002. |
Stoffels, E. et al., “Superficial Treatment of Mammalian Cells using Plasma Needle”, J. Phys. D: Appl. Phys. 26, pp. 2908-2913, Nov. 19, 2003. |
Stoffels, E. et al., “Plasma Needle”, Eindhoven University of Technology, 1 pg, Nov. 28, 2003. |
Stoffels, E. et al., “Plasma Physicists Move into Medicine”, Physicsweb, 1 pg, Nov. 2003. |
Stoffels, E. et al., “Plasma Treated Tissue Engineered Skin to Study Skin Damage”, Biomechanics and Tissue Engineering, Materials Technology, 1 pg, 2003. |
Stoffels, E. et al., “Plasma Treatment of Dental Cavities: A Feasibility Study”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1540-1542, Aug. 2004. |
Stoffels, E. et al., “The Effects of UV Irradiation and Gas Plasma Treatment on Living Mammalian Cells and Bacteria: A Comparative Approach”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1544-1550, Aug. 2004. |
Stoffels, E. et al., “Electrical and Optical Characterization of the Plasma Needle”, New Journal of Physics 6, pp. 1-14, Oct. 28, 2004. |
Stoffels, E. et al., “Where Plasma Meets Plasma”, Eindhoven University of Technology, 23 pgs, 2004. |
Stoffels, E. et al., “Gas Plasma effects on Living Cells”, Physica Scripta, T107, pp. 79-82, 2004. |
Stoffels, E. et al., “Plasma Treatment of Mammalian Vascular Cells: A Quantitative Description”, IEEE Transaction on Plasma Science, vol. 33, No. 2, pp. 771-775, Apr. 2005. |
Stoffels, E. et al., “Deactivation of Escherichia coli by the Plasma Needle”, J. Phys. D: Appl. Phys. 38, pp. 1716-1721, May 20, 2005. |
Stoffels, E. et al., “Development of a Gas Plasma Catheter for Gas Plasma Surgery”, XXVIIth ICPIG, Endoven University of Technology, pp. 18-22, Jul. 2005. |
Stoffels, E. et al., “Development of a Smart Positioning Sensor for the Plasma Needle”, Plasma Sources Sci. Technol. 15, pp. 582-589, Jun. 27, 2006. |
Stoffels, E. et al., Killing of S. mutans Bacteria Using a Plasma Needle at Atmospheric Pressure, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1317-1324, Aug. 2006. |
Stoffels, E. et al., “Plasma-Needle Treatment of Substrates with Respect to Wettability and Growth of Excherichia coli and Streptococcus mutans”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1325-1330, Aug. 2006. |
Stoffels, E. et al., “Reattachment and Apoptosis after Plasma-Needle Treatment of Cultured Cells”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1331-1336, Aug. 2006. |
Stoffels, E. et al., “UV Excimer Lamp Irradiation of Fibroblasts: The Influence on Antioxidant Homostasis”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1359-1364, Aug. 2006. |
Stoffels, E. et al., “Plasma Needle for In Vivo Medical Treatment: Recent Developments and Perspectives”, Plasma Sources Sci. Technol. 15, pp. S169-S180, Oct. 6, 2006. |
Swain, C.P., et al., “Which Electrode, A Comparison of four endoscopic methods of electrocoagulation in experimental bleeding ulcers” Gut vol. 25, pp. 1424-1431, 1987. |
Tucker, R. et al., Abstract P14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”, Nov. 1989. |
Tucker, R. et al. “A Comparison of Urologic Application of Bipolar Versus Monopolar Five French Electrosurgical Probes” J. of Urology vol. 141, pp. 662-665, 1989. |
Tucker, R. et al. “In vivo effect of 5 French Bipolar and Monopolar Electrosurgical Probes on the Porcine Bladder” Urological Research vol. 18, pp. 291-294, 1990. |
Tucker, R. et al., “Demodulated Low Frequency Currents from Electrosurgical Procedures,” Surgery, Gynecology and Obstetrics, 159:39-43, 1984. |
Tucker et al. “The interaction between electrosurgical generators, endoscopic electrodes, and tissue,” Gastrointestinal Endoscopy, vol. 38, No. 2, pp. 118-122, 1992. |
Valley Forge Scientific Corp., “Summary of Safety and Effective Information from 510K”, 2pgs, 1991. |
Valley Forge's New Products, Clinica, 475, 5, Nov. 6, 1991. |
Valleylab SSE2L Instruction Manual, 11 pgs, Jan. 6, 1983. |
Valleylab, Inc. “Valleylab Part No. 945 100 102 A” Surgistat Service Manual, pp. 1-46, Jul. 1988. |
Wattiez, Arnaud et al., “Electrosurgery in Operative Endoscopy,” Electrosurgical Effects, Blackwell Science, pp. 85-93, 1995. |
Wyeth, “Electrosurgical Unit” pp. 1181-1202, 2000. |
Buchelt, et al. “Excimer Laser Ablation of Fibrocartilage: An In Vitro and In Vivo Study”, Lasers in Surgery and Medicine, vol. 11, pp. 271-279, 1991. |
Costello et al., “Nd: YAG Laser Ablation of the Prostate as a Treatment for Benign Prostatic Hypertrophy”, Lasers in Surgery and Medicine, vol. 12, pp. 121-124, 1992. |
Rand et al., “Effect of Elecctrocautery on Fresh Human Articular Cartilage”, J. Arthro. Surg., vol. 1, pp. 242-246, 1985. |
Seal et al., “Thermal Characteristics and the Lumbar Disc: Evaluation of a Novel Approach to Targeted Intradiscal Thermal Therapy”, NASS-APS First Joint Meeting, Charleston SC, Apr. 1998. |
PCT International Search Report for PCT/US99/03339, 1 pg, Mailed May 14, 1999. |
PCT International Search Report for PCT/US99/17821, 1 pg., Mailed Oct. 19, 1999. |
PCT International Search Report for PCT/US00/13706. 1 pg., Mailed Jul. 31, 2000. |
PCT International Search Report for PCT/US00/28267, 1 pg., Mailed Mar. 23, 2001. |
PCT International Search Report for PCT/US01/15728, 1 pg., Mailed Oct. 18, 2001. |
PCT International Preliminary Examination Report for PCT/US01/15728, 4 pgs, Jan. 23, 2003. |
PCT International Search Report for PCT/US02/29469, 1 pg., Mailed May 22, 2003. |
PCT International Search Report for PCT/US03/27745, 1 pg., Mailed Jul. 2, 2004. |
PCT International Search Report for PCT/US05/20774 1 pg., Mailed Oct. 26, 2005. |
PCT Written Opinon of the International Searching Authority for PCT/US05/20774, 4pgs., Mailed Oct. 26, 2005. |
PCT International Search Report for PCT/US04/34949, 1 pg., Mailed Mar. 28, 2006. |
PCT Written Opinon of the International Searching Authority for PCT/US04/34949, 3pgs., Mailed Mar. 28, 2006. |
Supplementary EP Search Report for EP97932609, 2 pgs, Dec. 19, 2000. |
EPO Communication, Supplementary EP Search Report for EP99934236, 3 pgs, Mailed Oct. 9, 2001. |
EPO Communication, Supplementary EP Search Report for EP01935554, 5 pgs, Mailed Feb. 27, 2006. |
EPO Communication, Supplementary EP Search Report for EP03749423, 3 pgs, Mailed Mar. 21, 2006. |
EPO Communication, Supplementary EP Search Report for EP00936062, 6 pgs, Mailed Mar. 11, 2008. |
PCT International Search Report and Written Opinion for PCT/US07/63198 10 pgs, Mailed Mar. 26, 2008. |
EPO Communication, Supplementary EP Search Report for EP 05760511, 5 pgs, Jan. 12, 2011. |
UK Search Report for GB 1108507.3 5 pgs, Sep. 23, 2011. |
Number | Date | Country | |
---|---|---|---|
20110288539 A1 | Nov 2011 | US |